Gabapentin as add-on treatment for somatoform disorder: a case report

Riccardo Guglielmo; Giovanni Martinotti; Luigi Janiri

doi:10.1097/WNF.0b013e31823e669b

Gabapentin as add-on treatment for somatoform disorder: a case report

Riccardo Guglielmo
, Giovanni Martinotti
, Luigi Janiri

Risultato della ricerca: Contributo in rivista › Articolo

3 Citazioni (Scopus)

Abstract

Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.

Lingua originale	Inglese
pagine (da-a)	45-46
Numero di pagine	2
Rivista	Clinical Neuropharmacology
Volume	35
DOI	https://doi.org/10.1097/WNF.0b013e31823e669b
Stato di pubblicazione	Pubblicato - 2012

Keywords

Gabapentin
Somatoform Disorders

Accesso al documento

10.1097/WNF.0b013e31823e669b

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{8520c554a5ce4bfea568310b3ce52257,

title = "Gabapentin as add-on treatment for somatoform disorder: a case report",

abstract = "Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.",

keywords = "Gabapentin, Somatoform Disorders, Gabapentin, Somatoform Disorders",

author = "Riccardo Guglielmo and Giovanni Martinotti and Luigi Janiri",

year = "2012",

doi = "10.1097/WNF.0b013e31823e669b",

language = "English",

volume = "35",

pages = "45--46",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Gabapentin as add-on treatment for somatoform disorder: a case report

AU - Guglielmo, Riccardo

AU - Martinotti, Giovanni

AU - Janiri, Luigi

PY - 2012

Y1 - 2012

N2 - Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.

AB - Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.

KW - Gabapentin

KW - Somatoform Disorders

KW - Gabapentin

KW - Somatoform Disorders

UR - http://hdl.handle.net/10807/8736

U2 - 10.1097/WNF.0b013e31823e669b

DO - 10.1097/WNF.0b013e31823e669b

M3 - Article

SN - 0362-5664

VL - 35

SP - 45

EP - 46

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

ER -

Gabapentin as add-on treatment for somatoform disorder: a case report

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo